Grenada Broadcasting Network

6th July 2022

  

Advertisement

Advertisement

The Ministry of Health is assuring the public that the brands of Zantac recently recalled by the US Food and Drug Administration (FDA) are not imported into the country.

On Tuesday a statement from the Health Ministry says since the announcement from the Food and Drug Administration (FDA) last month (September), it has been in contact with the St. Lucia based Organisation of Eastern Caribbean States-Pooled Procurement Services (OECS-PPS) and has been advised, and can categorically state that the brands affected by the voluntary recall are not imported by local supplies and as such is not in Grenada’s hospitals and clinics.

The health ministry further added that an investigation carried out by its pharmacy department also found that the brands of Zantac subjected to the voluntary recall are not being imported by private pharmacies locally.

The Ministry says it will continue to monitor the situation as it evolves and keep the public informed.

The US Food and Drug Administration (FDA) announced that In September 2019 that preliminary tests found low levels of N-nitrosodimethylamine (NDMA) in the heartburn relief drug Ranitidine.

Reports are that the FDA has found a probable human carcinogen (a substance that can cause cancer) in some brands of Ranitidine.

Ranitidine (also known by its brand name, Zantac, is available both over the counter (OTC) and by prescription. While (OTC) Ranitidine is commonly used to relieve and prevent heartburn, prescription strengths are also used to treat and prevent more serious ulcers in the stomach and intestines.

Multiple companies sell generic versions of both the OTC and prescription products.

Following the announcement from the FDA, manufacturers of the brands of Ranitidine in which the low levels of (NDMA) were found have initiated a voluntary recall of the medication.

Canada and France are two countries that were proactive in recalling the drug.

In the US CVS and other pharmacies also removed it from their shelves.

The FDA and other agencies around the world will continue to investigate Ranitidine and more details will be made available.

Facebook Comments